PT-141
Bremelanotide · PT-141
PT-141 (bremelanotide) is a synthetic peptide studied in in-vitro and preclinical research as a melanocortin-receptor agonist (MC1R/MC4R). Research reagent only — not for human consumption.
Key facts
- Class
- Melanocortin analogue
- Targets
- MC1R / MC4R
- Form
- Lyophilised (powder)
- Status
- Research Use Only
Study library
All results on PubMedPT-141 Palatin.
Hedlund P · Current opinion in investigational drugs (London, England : 2000) · 2004
Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment.
Pettigrew JA, et al. · Journal of midwifery & women's health · 2021
Bremelanotide.
— · 2006
Bremelanotide.
— · 2012
Bremelanotide: First Approval.
Dhillon S, et al. · Drugs · 2019
Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.
Toledo RG, et al. · Journal of minimally invasive gynecology · 2026
An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.
Diamond LE, et al. · The journal of sexual medicine · 2006
Safety Profile of Bremelanotide Across the Clinical Development Program.
Clayton AH, et al. · Journal of women's health (2002) · 2022
Targeting the central melanocortin system for the treatment of metabolic disorders.
Sweeney P, et al. · Nature reviews. Endocrinology · 2023
Bremelanotide for Treatment of Female Hypoactive Sexual Desire.
Edinoff AN, et al. · Neurology international · 2022
Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder.
Mayer D, et al. · The Annals of pharmacotherapy · 2020
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
Kingsberg SA, et al. · Obstetrics and gynecology · 2019
Results retrieved live from PubMed (NCBI). Research literature only — no medical advice.
Research peptides — Research Use Only
- Not for human consumption
- Not for the diagnosis, treatment or prevention of any disease